Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants

B. Drysdale, Simon; Cathie, Katrina; Flamein, Florence; Knuf, Markus; M. Collins, Andrea; Hill, Helen; W. Kaiser, Friedrich; Cohen, Robert; Pinquier, Didier; Felter, Christian; Vassilouthis, Natalya; Jin, Jing; Bangert, Mathieu; Mari, Karine; Nteene, Rapi; Wagué, Sophie; Roberts, Michelle; Tissières, Pierre; Royal, Simon; N. Faust, Saul

doi:10.1056/nejmoa2309189

Public

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants

Published in New England Journal of Medicine • Dec 27, 2023

Authors:

Simon B. Drysdale

Katrina Cathie

Florence Flamein

Abstract

BACKGROUND: The safety of the monoclonal antibody nirsevimab and the effect of nirsevimab on hospitalizations for respiratory syncytial virus (RSV)-associated lower respiratory tract infection when administered in healthy infants are unclear. METHODS: In a pragmatic trial, we randomly assigned, in a...

Subject

Medicine

Lower respiratory tract infection

Respiratory tract

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!